Accelerant Stock Retreats in Premarket Following Friday's Surge
Earnings James Calloway

Accelerant Stock Retreats in Premarket Following Friday's Surge

Accelerant Holdings stock declined nearly 3% in premarket activity, paring a sharp rally from the prior session. The market now focuses on the company's upcoming audited financial release and forward outlook.

ARX
Accelerant Stock Retreats in Premarket Following Friday's Surge
Earnings James Calloway

Accelerant Stock Retreats in Premarket Following Friday's Surge

Accelerant Holdings stock declined nearly 3% in premarket trading Monday, paring back a significant 10% surge from the previous session. Investors are focused on the company's upcoming audited financial results and 2026 guidance scheduled for March 19.

ARX
BioCryst Shares Slip on New Hereditary Angioedema Drug Data
Analysis Daniel Marsh

BioCryst Shares Slip on New Hereditary Angioedema Drug Data

BioCryst Pharmaceuticals shares fell premarket following new clinical data for its hereditary angioedema candidate navenibart. The company reaffirmed its 2026 revenue outlook and plans a Phase 3 filing by late 2027.

BCRX XLV
BioCryst Shares Slide on HAE Drug Data, Focus Shifts to Cowen Conference
Analysis Daniel Marsh

BioCryst Shares Slide on HAE Drug Data, Focus Shifts to Cowen Conference

BioCryst Pharmaceuticals shares fell nearly 3% in premarket trading following new clinical data for its hereditary angioedema candidate navenibart. The company maintained its 2026 revenue outlook for ORLADEYO.

BCRX
BioCryst Shares Slip on New HAE Drug Data, Focus Shifts to Cowen Conference
Markets Daniel Marsh

BioCryst Shares Slip on New HAE Drug Data, Focus Shifts to Cowen Conference

BioCryst Pharmaceuticals shares fell premarket following new clinical data for its hereditary angioedema candidate navenibart. The company maintained its 2026 revenue outlook for ORLADEYO and targets a late-2027 regulatory submission.

BCRX
Geopolitical Tensions Weigh on VOO, S&P 500 Futures Slide
Markets Daniel Marsh

Geopolitical Tensions Weigh on VOO, S&P 500 Futures Slide

Vanguard's S&P 500 ETF declined approximately 1% before the bell Monday following military strikes on Iran, with oil surging 8% and gold futures rising 3.4% as investors sought safety.

VOO SPY NVDA USO GLD
Vanguard S&P 500 ETF Slides on Iran Strike Fears, Oil Surge
Markets Daniel Marsh

Vanguard S&P 500 ETF Slides on Iran Strike Fears, Oil Surge

Vanguard's S&P 500 ETF declined approximately 1% in Monday's premarket trading following military action against Iran, with oil prices jumping 8% and gold futures rising 3.4% as investors sought safety.

VOO SPY USO GLD NVS NVDA XLE XLF XLV XLK FXI MCHI
Geopolitical Tensions Weigh on S&P 500 ETF as Oil Spikes
Markets Daniel Marsh

Geopolitical Tensions Weigh on S&P 500 ETF as Oil Spikes

The Vanguard S&P 500 ETF declined approximately 1% in premarket trading Monday following military action against Iran, sparking a surge in oil and safe-haven assets. U.S. stock index futures dropped over 1%.

VOO SPY USO GLD NVS NVDA XLE
Block Shares Retreat After AI-Driven Rally, Analysts Split on Restructuring
Technology Sarah Chen

Block Shares Retreat After AI-Driven Rally, Analysts Split on Restructuring

Block shares declined 3.3% to $61.57 in premarket activity Monday, cooling from Friday's 16.8% surge driven by restructuring plans. Analysts remain divided on the long-term implications of the company's AI-focused job cuts.

SQ SPY
Block Shares Retreat After AI-Driven Restructuring Rally
Technology Sarah Chen

Block Shares Retreat After AI-Driven Restructuring Rally

Block shares declined 3.3% to $61.57 in premarket activity Monday, cooling from Friday's 16.8% rally driven by workforce reductions and an improved profit forecast. Morgan Stanley upgraded the stock to Overweight with a $93 target.

SQ SPY
Block Shares Retreat After AI-Driven Rally, Analysts Split on Outlook
Technology Sarah Chen

Block Shares Retreat After AI-Driven Rally, Analysts Split on Outlook

Block shares declined 3.3% to $61.57 in premarket activity Monday, cooling from Friday's 16.8% surge driven by workforce reductions and an improved profit outlook. Analysts remain divided on the long-term implications.

SQ
Dentsply Sirona Shares Retreat After Analyst Target Hikes, Dividend Cut
Earnings James Calloway

Dentsply Sirona Shares Retreat After Analyst Target Hikes, Dividend Cut

Dentsply Sirona shares declined in premarket trading Monday, giving back a portion of Friday's sharp gains, as analysts adjusted targets following quarterly results and the company outlined a major restructuring.

XRAY